Rob Stein

The Biden Administration is taking a far more aggressive, nationally coordinated approach to the pandemic. We hear more about how it plans to support vaccination efforts.

Daily numbers of new cases are finally starting to wane, and hospitalizations are down slightly. But health care systems are still overburdened and another resurgence remains a threat.

The deaths caused by the pandemic appear to be shortening overall life expectancy in the U.S. by 1.13 years, which would be the largest single decline in at least 40 years.

Mask-wearing hit an all-time high, but other COVID-19 precautions are less common now than last spring, a survey finds. Experts worry we're ill-prepared for the spread of more infectious new variants.

The pandemic has never been this bad in the U.S. There is not enough data yet to say whether the holidays accelerated the coronavirus surge, but many experts believe that the case.

Experts argue that pushing out more COVID-19 vaccine doses to states sooner may be a good idea, even if it means there's a chance some people's second dose gets delayed.

President-elect Biden plans to release almost all available doses of COVID-19 vaccines, stepping away from the Trump administration policy to hold back about half of the supplies for booster shots.

Critics say the vaccine rollout suffers from the same problems that have plagued the response to the pandemic for testing and other responses: lack of aggressive and coordinated federal leadership.

The U.S. conducts nearly 2 million coronavirus tests daily. A new analysis shows millions more are needed to protect the most vulnerable. Use our tool to see how your state is doing.

A CDC panel recommends that people over 75 and front-line essential workers should be prioritized as the next group to be vaccinated against the coronavirus.

Epidemiologists are still puzzling over how much of an impact Thanksgiving had on the pandemic in the U.S. Meanwhile, infections, hospitalizations and deaths are still surging as Christmas approaches.

The Food and Drug Administration on Tuesday authorized the test. It will cost about $30 and be available by January, according the Australian company that makes it, Ellume.

The new tests produce results completely at home within 15 minutes. Experts say they could be a 'game-changer' in helping people find out quickly if they need to isolate.

As the first patient to receive an experimental treatment that relied on the gene-editing technique CRISPR continues to do well 17 months later, more patients seem to be benefiting, too.

On Monday, health care workers began administering the first shots of a COVID-19 vaccine. NPR discusses the latest news and explores the challenges the U.S. could face in vaccinating people.

The Centers for Disease Control and Prevention changed its recommendations. Now it says people without coronavirus symptoms need to quarantine for 10 days, or seven — if they then test negative.

Social distancing fell dramatically between spring and fall and the gap between Democrats and Republicans widened. But both ends of the political spectrum agree on some measures to fight COVID-19.

A survey shows social distancing dropped between April and late fall, especially in states currently hit hardest by COVID-19. The partisan chasm in support of measures to stop the virus widened.

Federal health officials could reduce the quarantine from the currently recommended 14 days to as few as seven for people who test negative for the virus.

Demand for COVID-19 testing has gone up as the virus surges across the nation. Luckily, testing has gotten better and people who want tests now have several options.